Cargando…
FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas
Colorectal carcinoma cells have recently been shown to express Fas ligand (FasL). This ligand could allow the tumour cells to evade activated tumour-infiltrating lymphocytes (TILs) by inducing their apoptosis and would thus promote tumour survival and possibly metastasis formation. To test this hypo...
Autores principales: | Mann, B, Gratchev, A, Böhm, C, Demel, G, Trojanek, B, Schmidt-Wolf, I, Stein, H, Hanski, C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362258/ https://www.ncbi.nlm.nih.gov/pubmed/10098769 http://dx.doi.org/10.1038/sj.bjc.6690202 |
Ejemplares similares
-
The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability
por: Henkler, Frank, et al.
Publicado: (2005) -
Role of the Fas/FasL pathway in HIV or SIV disease
por: Poonia, Bhawna, et al.
Publicado: (2009) -
The Fas/FasL System in Reproduction: Survival and Apoptosis
por: Mor, Gil, et al.
Publicado: (2002) -
Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2020) -
Involvement of Fas/FasL pathway in the murine model of atopic dermatitis
por: Bień, Karolina, et al.
Publicado: (2017)